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Introduction
The emergence of opportunistic fungal infections, 
especially in immunocompromised individuals, highlights 
the need to elucidate new therapeutic options, especially 
because the fungi involved usually have remarkable 
morphological plasticity and express genes involved in 
the mechanisms of resistance to antifungal agents (1). In 
fact, indiscriminate use and the small number of available 
antifungal agents have promoted the development of 
resistant strains, especially in immunocompromised 
individuals (2). This fact justifies the development of new 
therapies for use in clinical practice. Among these new 
therapies, natural products stand out; they are considered 
sources of bioactive molecules with potential therapeutic 
applications in medicine (3).
 In search of phytochemicals with potential antimicrobial 
activity in the past few years, attentions have been directed 
on Zataria multiflora quite reasonably. From the vegetable 
families, Lamiaceae is one of the biggest families, with 
worldwide distribution, which has 200 genuses and 2000-
5000 species of aromatic bush and short shrubs producing 
terpenes and other types of compounds that are stored in 
epidermal gland of leafs, stalks and generative organs (4). 
Zataria multiflora Boiss. (Avishan-e-Shirazi in Persian 
and Saatar or Zaatar in the old Iranian medical books) 
is a thyme-like plant, which is a member of this family 
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Introduction: Zataria multiflora is a valuable medicinal plant from Lamiaceae family with various 
pharmacological and therapeutic properties. In this article we reviewed the various aspects of Z. 
multiflora properties including botanical characteristics, chemical composition, anti-fungal and 
anti-mycotoxin activity and fungal ultrastructural changes.
Methods: Google Scholar, PubMed, EBSCO, Directory of open access journals (DOAJ), EMBASE, 
and Web of Science were searched using the keywords Z. multiflora and pathogenic and toxigenic 
fungi. 
Results: The essential oil (EO) of Z. multiflora is frequently used in pharmaceutical industries. 
Thymol and carvacrol are the most important active components of Z. multiflora that are used 
for the treatment of a wide variety of diseases such as candidiasis and dermatophytosis. Aflatoxin 
production inhibitory effect of Z. multiflora EO was at the transcription level and this herb may 
cause reduction in aflatoxin biosynthesis. Ultrastructural changes showed that the main sites of 
action of EO were the plasma membrane and cell wall of fungi.
Conclusion: Zataria multiflora has the potential to be considered as a new natural drug for the 
treatment of some fungal infections. Morphological and structural changes may be one of the 
mechanisms involved in growth inhibition of the fungi and reducing aflatoxin production by Z. 
multiflora EO.
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and is the aborigine of Iran, Afghanistan and Pakistan 
(5). Zataria multiflora can be recognized by the orbicular, 
densely gland-dotted, ovate leaves and the dense white, 
hairy, round buds on the leaf axils. It is an aromatic shrub 
that reaches 60-90 cm in height. Mature branches are 
woody and leafless whereas young branches are white 
with dense glandular, spreading, pilose indumentums. 
Leaves (5-10 × 5-10 mm2) are orbicular ovate to orbicular. 
Flowering stems are usually un-branched, sometimes 
having short lateral branches. Flowers are white, sub-
sessile, very small and often male sterile (6). Zataria 
multiflora (aerial parts) is not only a popular condimental 
plant but is also used in traditional folk remedies for its 
anti-microbial, analgesic, carminative, anthelmintic and 
anti-diarrheal properties (7). Modern pharmacological 
studies have shown that Z. multiflora possesses wide 
ranging biological properties including anti-nociceptive, 
anti-microbial, spasmolytic and anti-inflammatory effects 
(5,8-10). Currently, some pharmaceutical forms of this 
plant, such as syrups, oral drops, soft capsules and vaginal 
creams are sold as treatment remedies for various diseases. 
To outline the extensive uses of Z. multiflora in healthcare 
and medicine and to provide a probable scope for future 
research, several pharmacological and clinical studies on 
this plant and its active components are provided in this 
review article. 
Methods
Google Scholar, PubMed, EBSCO, Directory of open 
access journals (DOAJ), EMBASE, and Web of Science 
were searched using the keywords Z. multiflora and 
pathogenic and toxigenic fungi. 
Chemical composition of Zataria multiflora 
Various extraction techniques like distillation, effleurage, 
CO2 extraction, expression and solvent extraction are 
applied for essential oil (EO) extraction from various 
plants. But conventional methods that are usually used 
to extract EO oil from plants, are the distillation methods 
like steam-distillation, hydro-distillation and water-
steam-distillation method.
Quantitatively, the most abundant components 
in hydrodistilled Z. multiflora EOs are oxygenated 
monoterpenes (approximately 70%), followed (in order) by 
monoterpene hydrocarbons, sesquiterpene hydrocarbons 
and oxygenated sesquiterpenes (10,11). Two studies from 
Pakistan identified carvacrol as the main constituent of the 
oil (12,13). To date, a large number of studies have focused 
on Z. multiflora EO: some reported carvacrol as the main 
compound, but others reported thymol, the isomer of 
carvacrol, as the main compound. Saei-Dehkordi et al (14) 
collected Z. multiflora from five different areas of Iran and 
analyzed its EOs. According to the GC–MS data, the main 
EO constituents remained similar between plants from 
different geographical regions, but their relative quantities 
differed among plants from different regions. Thymol was 
the most abundant compound among all constituents in 
all samples (14). In a study conducted by Shokri et al (15), 
Z. multiflora main components were carvacrol (61%) and 
thymol (25%). Additionally, Saleem et al (16) showed 
that thymol was the main constituent of the fresh plant 
(73.21%), while carvacrol was the primary constituent 
in the dried plant (62.87%). It is clear that geographical 
variation, cultivar differences, stage of plant growth, 
preparation process and other factors may influence the 
EO composition both quantitatively and qualitatively. 
According to previous studies, the EOs of Z. multiflora 
contain significant amounts of thymol and carvacrol, 
which are well-known anti-fungal agents (17-19). 
p-Cymene is the other main component in Z. multiflora 
EO. Zatariol, zataroside A (glycoside and non-volatile), 
zataroside B (glycoside and non-volatile), multiflotriol 
and multiflorol have been reported as new derivatives of 
p-cymene isolated from Z. multiflora (20,21). Linalool, 
caryophyllene, γ-terpinene and borneol are some of the 
other main components in the EOs (22).
Zataria multiflora also contains other compounds 
belonging to different classes of natural products, including 
alkanes such as n-nonacosane (C29), n-hentriacontane 
(C31), n-dotriacontane (C32), n-tritriacontane (C33) and 
n-pentatriacontane (C35); fatty acids such as behenic 
acid (C22), lignoceric acid (C24), cerotic acid (C26) and 
montanic acid (C28) (23); phytosterols such as β-sitosterol 
and stigmasterol; triterpenes such as betulin, betulinic 
acid and oleanolic acid (24); and hydroxycinnamic acids 
such as rosmarinic acid (25). Moreover, flavonoids such as 
apigenin, luteolin and 6-hydroxyluteolin are also among 
the phytochemicals reported from Z. multiflora (22). This 
plant also contains small amounts of tannins, resins and 
saponins while lacking alkaloids (26).
Pharmacological and therapeutic activities of Zataria 
multiflora
1. Anti-yeast activity of Zataria multiflora 
Various studies have shown that many species of yeasts, 
especially Candida and Malassezia species, have developed 
resistance to standard antifungal drugs. Nowadays 
traditional medicine and the use of herbal medicines to 
treat yeast infections are important because herbal medi-
cines have fewer side effects and are less likely to develop 
drug resistance compared with chemical ones (27,28). 
Medicinal plants have been shown to eliminate the drug 
resistant yeasts and can be beneficial for their therapeutic 
effects (29). Zarei-Mahmoudabadi et al evaluated 
anti-Candida activity of three extracts of Z. multiflora 
(aqueous, ethanolic and methanolic) against 14 isolates 
of Candida. Aqueous extract of Z. multiflora showed 
no activity against Candida species. The ethanolic and 
methanolic extracts showed remarkable activities against 
Candida species. The minimum inhibitory concentration 
(MIC) for both extract was between 50 and 150 mg/L. 
The lowest MIC was for seven isolates of C. albicans 
(125 mg/L). Others MICs were respectively C. glabrata 
(126 mg/L), C. parapsilosis (125 mg/L) and C. tropicalis 
(131 mg/L). Totally, the MIC of ethanolic extract for 14 
isolates of Candida was 127 mg/L. Both C. albicans and 
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C. parapsilosis were more susceptible than other species. 
The isolates of C. parapsilosis (64 mg/L) were more 
susceptible to methanolic extract of Z. multiflora, followed 
by C. glabrata (66 mg/L), C. albicans (76 mg/L) and C. 
tropicalis (76 mg/L). In addition, the MIC of methanolic 
extract for tested Candida was 70 mg/L. In that study 
methanolic extract showed more activities than ethanolic 
extract against 14 isolates of Candida (30). In Moghim et 
al (31) study, the obtained MIC of Z. multiflora extract 
was 0.13 mg/mL for C. albicans, which was lower than the 
effect on C. albicans obtained for this extract in the study 
of Zarei Mahmoudabadi et al (30). In another study by 
Fuladi et al (32), the MIC of Z. multiflora methanol and 
ethanol extracts were estimated to be 0.079 and 0.125 mg/
mL, respectively. The contrasting results could be due 
to the different species of Z. multiflora, plant chemical 
compounds and/or methodologies. Katiraei et al (33) 
compared the MIC of EOs of Z. multiflora, Geranium and 
Artemisia with regard to the growth of C. albicans isolates 
resistant to azole drugs. They showed that the MIC levels 
of EOs of the plants were statistically significant from those 
of azoles. In that study, the obtained MIC of Z. multiflora 
for C. albi cans was 0.18 mg/mL. In a study conducted 
by Esfandiary et al (34), a set of C. glabrata (29 strains), 
C. krusei (3 stains) and C. patapsilosis (2 strains) were 
studied. The results revealed that 33 isolates were resistant 
(MIC = 64 μg/mL), 4 isolates were susceptible (MIC ≤ 8 
μg/mL) and 7 isolates had dose-dependent susceptibility 
(MIC = 16-32 μg/mL) to fluconazole, respectively. With 
regard to fluconazole, high resistance rate was observed in 
C. glabrata and C. krusei. However, ciclopirox olamine was 
found to inhibit the growth of all non-albicans Candida 
species (MIC ≤8 μg/mL). Also, favorable anti-fungal 
activity against non-albicans Candida species was obtained 
by Z. multiflora despite having a wide range of MICs 
(34.9-139.5 mg/mL). Mohammadi-Pourfard and Kavoosi 
(35) showed that EO from Z. multiflora significantly 
(P < 0.01) inhibited the growth of C. albicans. MIC for C. 
albicans was 2.8 ± 0.8 mg/mL of EO. At concentration > 
5 mg/mL, EO significantly (P < 0.01) reduced the growth 
of C. albicans by 100%. However, the aqueous extract did 
not show any such activity at any concentration used. In 
addition, Zomorodian et al (36) determined the MICs 
and minimum fungicidal concentrations (MFCs) of the 
EO from Z. multiflora against Candida and Trichosporon 
species, showing strong anti-yeast activities with MIC 
values ranging from 0.007 to 0.5 μg/mL. This finding is 
similar to that of the study by Mahboubi et al (37) who 
reported strong anti-Candida activity of Z. multiflora EO 
with high thymol and carvacrol concentrations.
In a randomized clinical trial conducted by Khosravi 
et al (38), the application of 0.1% Z. multiflora cream in 
patients with acute vaginal candidiasis decreased vulvar 
pruritus in 80.9% of patients, vaginal pruritus in 65.5% 
of patients, vaginal burning in 73.9% of patients, urinary 
burning in 100% of patients, painful intercourse in 92.6% 
of patients, and vaginal secretion in 90% of patients. In 
addition, 0.1% Z. multiflora cream reduced erythema 
and satellite vulvar lesions in 100% of patients, vulvar 
edema in 100% of patients, vaginal edema in 83.3% of 
patients, vulvo-vaginal excoriation and fissures in 92% of 
patients, and white, sticky vaginal secretions in 86.2% of 
patients. After treatment with 0.1% Z. multiflora cream 
a laboratory using standard methods reported negative 
mycologic results on microscopic evaluation for 90% of 
patients; negative mycologic cultures in 86.7% of patients; 
and negative mycologic results on microscopy and culture 
combined for 93.3% of patients (38). Abou Fazeli et al (39) 
demonstrated the activity of the EO against C. albicans. 
They also suggested Z. multiflora oil-containing vaginal 
suppositories as a successful replacement for current 
drugs for the treatment of vaginitis caused by C. albicans 
(39). In a comparative study, a 7-day therapy with Z. 
multiflora as an intravaginal cream was more effective 
than clotrimazole vaginal cream in the treatment of 
Candidal vaginitis (40). An open-label, randomized and 
controlled study with two parallel treatment groups was 
conducted to evaluate the efficacy of a miconazole 2% gel 
compared with a Z. multiflora 0.1% gel applied four times 
daily for two weeks in the treatment of Candida-associated 
denture stomatitis. The results indicated that the Z. 
multiflora gel reduced the surface erythema of the palate 
more efficiently than miconazole gel but did not reduce 
the colony count on the denture surface as efficiently as 
miconazole (41). In another study, the physicochemical 
properties and stability of creams containing different 
concentrations (1%–3%) of Z. multiflora were evaluated 
and suggested as a successful replacement in the treatment 
of C. albicans induced vaginitis. In a previous study by 
Khosravi et al (43), intraperitoneally administration of 64 
mg/kg of the EO in mice with systemic candidiasis had 
the highest efficacy in reducing C. albicans and produced 
39.5, 21.8, 141.5, 174 and 501-fold reductions in mean 
colony forming units per 0.1 gram in Candida infections 
of the liver, spleen, lungs, brain and kidneys, respectively, 
as compared to itraconazole. Avaei et al (44) demonstrated 
that Saccharomyces cerevisiae (MIC = 200 µg/mL and 
MFC = 1600 µg/mL) was more resistant than C. utilis to 
Z. multiflora EO.
Naeini et al (45) showed that Malassezia species were 
susceptible to Z. multiflora EO ranging from 10 to > 50 
mm (mean value: 28.1 mm). The highest inhibitory 
effect was recorded with Malassezia obtusa, followed by 
M. furfur and M. globosa. In another study conducted 
by Naeini et al (46), the EO from Z. multiflora presented 
anti-Malassezia activity against the tested yeasts. All 
Malassezia species were very susceptible to Z. multiflora 
EO, with MICs ranging from 0.015 to 0.06% (v/v), and 
approximately 52.4% of the strains had a MIC value of 
0.015% (v/v). The mean MIC values of the EO against M. 
sympodialis, M. furfur and M. pachydermatis were 0.03, 
0.024 and 0.02%, respectively. Khosravi et al (47) showed 
that Z. multiflora EO had the best anti-fungal activity 
against various Malassezia species isolated from dogs with 
atopic dermatitis, with MIC values ranging from 30 to 80 
µg/mL. M. nana isolate was the most susceptible one (30 
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µg/mL), while M. sloofiae isolates showed the highest MIC 
value (80 µg/mL) (P<0.05).
2. Anti-dermatophyte activity of Zataria multiflora 
Dermatophytes are the major cause of superficial 
mycoses, and remain a public health problem. They 
have the ability to invade keratinized tissues and cause 
dermatophytosis, the most common human contagious 
fungal disease (48). In recent years, the incidence of 
dermatophytosis has increased considerably, especially 
among individuals with impaired immunity, as well as in 
pediatric and geriatric populations (49). Some of these 
infections are still difficult to resolve completely, and 
remissions and relapses are often observed. The poor 
availability of antifungals and the increasing number of 
treatment failures have motivated current searches for 
therapeutic alternatives which can work effectively as 
potential anti-dermatophyte agents. Khosravi et al (50) 
showed that EO obtained from Z. multiflora possessed 
anti-fungal activity against a wide number of clinical 
isolates of various dermatophytes, with MIC ranging from 
0.25 to 4 mg/mL. However, variation of susceptibility from 
one species to another was evident. The MIC values were 
0.5 mg/mL for Microsporum canis and M. gypseum, 1.5 mg/
mL for Trichophyton mentagrophytes and Epidermophyton 
floccosum and 2 mg/mL for T. rubrum. The MFCs recorded 
for plant oil tested ranged from 0.5 to 8 mg/mL. In a study 
conducted by Effatpanah et al (51), total (100%) fungal 
growth inhibition was observed from Z. multiflora EO 
at concentration of > 8 mg/mL for T. mentagrophytes, T. 
rubrum and E. floccosum (P < 0.01). In another study, the 
minimum inhibitory activity of Z. multiflora methanolic 
extract against various dermatophytes was found to be 
approximately 0.5% (w/v) (42). 
3. Anti-filamentous fungi activity of Zataria multiflora 
Literature studies indicated that there are many reports 
on non-dermatophytic filamentous fungi causing fungal 
infections in human and animals and food spoilage 
(18,52). Gandomi Nasr-Abadi et al (53) found that all 
concentrations of EO from Z. multiflora had a significant 
effect on the growth and sporulation of Aspergillus 
flavus. Also, they reported the levels of MIC and MFC 
400 and 1000 ppm, respectively. In a study conducted by 
Mohammadi-Pourfard and Kavoosi (35), the EO from 
Z. multiflora at all tested concentrations significantly 
(P < 0.01) inhibited the growth of A. niger. MIC for A. niger 
was 2.2 ± 0.5 mg/mL of EO. At concentration > 5 mg/mL, 
EO significantly (P < 0.01) reduced the growth of A. niger 
by 100%. In a study by Shokri et al (18), the EO from Z. 
multiflora showed the inhibitory effects on four tested 
fungi including A. flavus, A. parasiticus, A. ochraceus and 
Fusarium verticillioides at all concentrations (500-2000 
ppm). It completely inhibited four fungi at 2000 ppm. At 
1000 ppm concentration, Z. multiflora EO significantly 
decreased the growth of Aspergillus species compared with 
the control, whereas it caused complete growth inhibition 
of F. verticillioides (P < 0.05). Therefore, F. verticillioides 
had a higher susceptibility than Aspergillus species against 
the EO tested. In addition, Nasseri et al (54) showed that 
the EO from Z. multiflora has anti-fungal activity; the 
lowest inhibition (75%) was observed in A. niger, while 
the highest inhibition (95.3%) was observed in Alternaria 
solani. The MICs for A. solani, Rhizoctonia solani, Rhizopus 
stolonifer, A. flavus, A. ochraceus and A. niger were 200, 
200, 200, 300, 300 and 200 ppm, respectively. In addition, 
the MFCs for A. solani, R. solani, R .stolonifer, A. niger 
and A. ochraceus were 600, 400, 300, 900 and 700 ppm, 
respectively, and none of the tested concentrations were 
fatal for A. flavus. A. solani and R. solani showed a strong 
susceptibility to Z. multiflora EO at all concentrations. The 
fungal pathogens studied were classified according to their 
susceptibility to the EO in the following order: A. solani > 
R. stolonifer > R. stolonifer > A. ochraceus > A. niger > A. 
flavus. Sharif Rohani et al (55) showed that dosage of 800 
ppm of Z. multiflora EO for Fusarium solani had obvious 
inhibitory rate. In a study by Amini et al (56), Z. multiflora 
EO was very effective on the four studied pathogenic fungi 
including Pythium aphanidermatum, R. solani, Fusarium 
graminearum and Sclerotinia sclerotiorum with growth 
inhibition average of 100% at 200 μL/L concentration. 
Nevertheless, MIC and MFC of the EO were variable 
depending to species of fungi. P. aphanidermatum and S. 
sclerotiorum were the most susceptible and most resistant 
to the studied EO with average growth inhibition 89.54% 
and 75.35%, respectively. Khosravi et al (57) determined 
the anti-fungal assay of EO from Z. multiflora against 
Saprolegnia parasitica isolated from fish eggs. The infected 
fish eggs were treated with EO oil at concentrations of 1, 
5, 10, 25, 50, and 100 ppm daily. The MIC of Z. multiflora 
EO against S. parasitica was 0.9 ppm. Z. multiflora at 
concentrations of 25, 50, and 100 ppm had significant 
differences in comparison with negative control (P<0.05). 
The most hatching rates were recorded with Z. multiflora 
(11%) EO. Z. multiflora was effective for the treatment of 
S. parasitica-infected rainbow trout eggs in aquaculture 
environment (57).
4.Inhibition of mycotoxin production by Zataria multiflora 
Fungi are significant spoilage microorganisms of 
foodstuffs during the storage, rendering them unfit 
for human consumption by retarding their nutritive 
value and sometimes by producing mycotoxins (58). 
Mycotoxins are polyketide secondary metabolites 
produced by the important food and feed contaminating 
species Aspergillus, Penicillium and Fusarium and are 
known as potent carcinogens for a wide variety of animal 
species, including humans (59). EOs and their phenolic 
compounds have been used as natural inhibitors of fungal 
growth and mycotoxin production to preserve foods and 
feeds in some countries during recent decades. Many of 
the spices and herbal EO which have been tested have 
an antagonistic effect against aflatoxigenic Aspergillus 
strains (60). Previous studies demonstrated that thymus 
EO, which mainly consists of thymol, has been shown to 
inhibit both the growth and aflatoxin production in A. 
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flavus and A. parasiticus (61,62). Yahyaraeyat et al (63) 
determined the effects of Z. multiflora EO on growth, 
aflatoxin production and transcription of aflatoxin 
biosynthesis pathway genes of A. parasiticus. The results 
showed that mycelial dry weight and aflatoxin production 
reduce in the presence of Z. multiflora EO (100 ppm) on 
day 5 of growth. It was found that the expression of nor-1, 
ver-1, omt-A and aflR genes was correlated with the ability 
of fungus to produce aflatoxins on day 5 in yeast extract 
sucrose medium. RT-PCR showed that in the presence 
of Z. multiflora EO (100 ppm), nor-1, ver-1 and omtA 
genes expression was reduced. It was suggested that toxin 
production inhibitory effects of Z. multiflora EO on day 5 
may be at the transcription level and this herb may cause 
reduction in aflatoxin biosynthesis pathway genes activity 
(63). Also, Gandomi et al (64) investigated the effect 
of Z. multiflora EO against growth, spore production 
and aflatoxin formation by A. flavus ATCC 15546. EO 
effectively inhibited radial growth and spore production on 
potato dextrose agar (PDA) in a dose-dependent manner. 
At 200 ppm, the radial growth and sporulation reduced by 
79.4% and 92.5%, respectively. The growth was completely 
prevented at EO ≥400 ppm on PDA, and MFC of the oil 
was estimated at 1000 ppm. The EO also significantly 
suppressed mycelial growth and aflatoxin synthesis in 
broth medium at all concentrations tested (P < 0.05). In 
that study, Z. multiflora EO had a significant inhibitory 
effect on aflatoxin formation, which was reduced by 31% 
and 99.4% at 50 and 150 ppm, respectively. In a similar 
study conducted by Farag et al (65), Z. multiflora EO 
was effective at concentrations ≥100 ppm in reducing 
aflatoxin formation by 50%. It has been suggested that the 
regulation of aflatoxin synthesis and conidiogenesis may 
be interlinked, since the loss of aflatoxigenic capabilities in 
the nonaflatoxigenic variant strains of A. parasiticus was 
correlated with alterations in the conidial morphology 
(66). Furthermore, it has been shown that lysis of the 
mycelia and spores of the toxigenic fungi are one of the 
characteristics of aflatoxin deactivation process (67).
It was shown by several investigators that chemical 
compounds of the EOs may cause reduction or stimulation 
in the toxin production and the anti-toxigenic effects of 
the EOs are not necessarily related to their anti-fungal 
activity. Values for growth inhibition were calculated as 
0.79 and 0.86mM for carvacrol and thymol, while for 
AFB1 and AFG1, it was reported as 0.50 and 0.06mM for 
carvacrol and 0.69 and 0.55mM for thymol (68). It was 
also shown by Wright et al (69) that aflatoxin production 
by the fungus was reduced by n-decyl aldehyde and 
hexanal, but was stimulated by octanal. Their results 
indicated that all three volatile compounds reduced radial 
growth but only n-decyl aldehyde significantly inhibits 
aflatoxin biosynthesis in A. parasiticus. Difference in anti-
fungal and aflatoxin inhibition efficacy of Thymus and 
Zataria EOs in different studies may be attributable to 
the EO compositions. Two major components of Thyme 
and Zataria are thymol and carvacrol. Thyme contains 
higher thymol than Zataria and Zataria contains more 
carvacrol. The other factors are also important for causing 
these differences such as differences in culture media 
used, culture conditions, temperature, pH and durations 
of culture.
There are little reports on the effect of Z. multiflora in 
inhibiting the other mycotoxins. In this regard, Vazquez 
et al (70) reported that phenolic compounds, i.e., thymol 
and eugenol, inhibited growth and citrinin production by 
Penicillium citrinum in some Galician cheeses. In another 
study by Noori et al (71), the EO from Z. multiflora 
significantly (P < 0.05) suppressed citrinin formation by 
P. citrinum in mozzarella cheese at all concentrations, as 
citrinin accumulation was reduced by 30% and 87% at 50 
and 1000 ppm, respectively.
Ultrastructural changes of fungi treated with Zataria 
multiflora
1. Scanning electron microscopy 
The effect of Z. multiflora EO on morphology of A. flavus 
observed by Scanning electron microscopy (SEM) is 
illustrated in Figure 1. Hyphae grown on PDA without 
EO showed swollen and turgid feature with smooth and 
uniform surface. In presence of 50 ppm EO, hyphae lost 
their turgidity and uniformity to some extent and these 
modifications increased at higher concentrations of EO. 
Furthermore, 100 ppm EO induced the shrinkage of the 
hyphae and formation of pits along the mycelia. The 
severity of damage increased with 200 ppm EO and the 
hyphae were frequently collapsed and their destruction 
was often evident (72).
2. Light and transmission electron microscopy 
Semi-thin sections of A. flavus grown in broth medium 
containing different concentrations of Z. multiflora 
Figure 1. Scanning electron micrographs ×2000,  Aspergillus 
flavus mycelia: (a) untreated; (b) treated with 50 ppm Zataria 
multiflora essential oil (EO); (c) treated with 100 ppm Z. multiflora 
EO; (d) treated with 200 ppm Z. multiflora EO (72).
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EO are illustrated in Figure 2. Longitudinal sections of 
untreated culture displayed normal mycelia that had a 
steady arrangement with continuous and homogenous 
cytoplasm (Figure 2a). Vacuolization of the cytoplasm 
was the major effect induced in the presence of 50 ppm 
EO, which led to the cell swelling (Figure 2b). However, 
mycelia treated with 100 ppm EO revealed greater damage 
characterized with detachment of the cell membrane from 
the cell wall that was collapsed and herniated in different 
intervals along the longitudinal sections resulting in the 
deformation of mycelia (Figure 2c). In presence of 150 
ppm EO, cell membrane was fully disconnected from 
the cell wall and mycelia obtained an electron-lucent 
appearance due to cytoplasm shedding from the cell 
(Figure 2d). Moreover, swelling and deformation of the 
mycelia were the other changes observed (Figure 2d). The 
concentration of 200 ppm EO effectively inhibited the 
germination of the fungal conidia and no mycelia formed 
at this concentration (Figure 2e). Some of the conidia had 
a normal shape but the others showed changes ranging 
from the vacuolization to cell membrane detachment and 
deformation (Figure 2e). With increasing EO concentration 
to 400 ppm, more severe damages including depletion of 
the cytoplasm and frequent degradation of the cell wall 
were observed (Figure 2f). Furthermore, deformation and 
destruction of conidia were often evident (Figure 2f) (72). 
Examination of ultrathin sections under transmission 
electron microscopy (TEM) resulted in more obvious 
findings. Untreated hypha was enclosed by the cell wall 
that was integrated and intact. The plasma membrane was 
Figure 2. Semi-thin sections × 1000, Aspergillus flavus grown 
in broth medium: (a) untreated; (b) treated with 50 ppm Zataria 
multiflora essential oil (EO); (c) treated with 100 ppm Z. multiflora 
EO; (d) treated with 150 ppm Z. multiflora EO; (e) treated with 200 
ppm Z. multiflora EO; (f) treated with 400 ppm Z. multiflora EO.
fully attached to the cell wall along the hypha and was 
smooth and unwrinkled. Cytoplasm was homogeneous 
and dense and intercellular septum was intact and healthy. 
At concentration of 50 ppm of Z. multiflora EO, the cell 
wall lost its integrity and uniformity to some extent. The 
cell membrane in some areas was detached from the 
cell wall and invaginated into the cytoplasm. The loss 
of cytoplasm density and vacuolization were the other 
changes. At concentration of 100 ppm of Z. multiflora 
EO, the plasma membrane was completely separated 
from the cell wall and vacuolization of the cytoplasm was 
more evident. The presence of 150 ppm of EO increased 
the severity of injury characterized by the depletion of 
cytoplasm content, and hypha lost its normal shape and 
was collapsed. In addition, detachment and fragmentation 
of the plasma membrane and formation of the lomasome, 
small membrane-bound vesicles, beneath the cell wall, 
were seen and membrane fragments were spread over 
the cytoplasm. At concentration of 200 ppm EO, no 
evident change was observed in the cell wall, whereas cell 
membrane was completely destroyed and cytoplasm was 
released from the cell. With increase in oil concentration 
to 400 ppm, complete destruction of the plasma membrane 
and cell wall was evident and hypha was totally free of 
cytoplasm (73).
Conclusion
 In summary, the microscopic examinations showed that 
Z. multiflora EO suppressed the size of the colony as well 
as sporulation of fungi. Mycelia treated with EO showed 
morphological alterations ranging from loss of turgidity 
and uniformity of mycelia at low concentrations of EO to 
evident destruction of the hyphae at higher concentration 
of EO. The major change at level as low as 50 ppm of EO 
was limited to vacuolization of cytoplasm resulting in 
cell swelling, while at higher concentrations, detachment 
of the cell membrane from the cell wall, deformation of 
mycelia and shedding the cytoplasm from the cell were the 
main alterations. These damages were well documented 
by TEM, which showed that the main sites of action of EO 
were the plasma membrane and cell wall. In conclusion, 
morphological and structural changes observed in this 
study may be one of the mechanisms involved in growth 
inhibition of the fungi and reducing aflatoxin production.
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